Achilles Therapeutics plc - American Depositary Shares (NQ:ACHL)

1.480 UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Achilles Therapeutics plc - American Depositary Shares

< Previous 1 2 3 Next >

These stocks have an unusual volume in today's session ↗

February 11, 2025

Unusual volume stocks in Tuesday's session

Via Chartmill

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

February 06, 2025

Let's explore the current happenings on the US markets on Thursday. Below, you'll find the stocks exhibiting unusual volume in today's session.

Via Chartmill

These stocks have an unusual volume in today's session ↗

February 05, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Discover the top movers in Tuesday's pre-market session. ↗

February 04, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 04, 2025

Via Benzinga

Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts ↗

December 24, 2024

Achilles Therapeutics announces a $12M deal with AstraZeneca for TRACERx data and plans job cuts following its strategic review.

Via Benzinga

Achilles Therapeutics Shares Are Trading Higher: What You Need To Know ↗

September 19, 2024

Shares of Achilles Therapeutics plc (NASDAQ: ACHL) are surging following a major strategic announcement from the company. The biotechnology firm revealed plans to discontinue its TIL-based cNeT program...

Via Benzinga

ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024 ↗

August 14, 2024

ACHL stock results show that Achilles Therapeutics met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer Vaccines

May 22, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

ACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024 ↗

May 08, 2024

ACHL stock results show that Achilles Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 08, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results ↗

April 04, 2024

U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.59% to 38,894.58 while the NASDAQ fell 0.10% to 16,261.88....

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 04, 2024

Via Benzinga

Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings ↗

April 04, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 150 points on Thursday. The Dow traded up 0.49% to 39,319.03 while the NASDAQ rose 1% to 16,4340. The S&P...

Via Benzinga

Topics Stocks

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 04, 2024

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...

Via Benzinga

ACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023 ↗

April 04, 2024

ACHL stock results show that Achilles Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 04, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 04, 2024

We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Thursday morning!

Via InvestorPlace

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights

April 04, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning

April 04, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference

February 05, 2024

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

December 18, 2023

Newly developed computational tools and large datasets with low bias will lead to robust neoantigen prediction and improved personalized cancer therapies

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights

November 13, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

10 Biotech Stocks Below Cash Value with Key Catalysts on the Horizon: An Analysis

October 23, 2023

Via ACCESSWIRE

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

Via Investor Brand Network

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

September 20, 2023

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

Via FinancialNewsMedia

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 07, 2023

Via Benzinga

Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

August 04, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

Achilles Therapeutics to Present at Upcoming Conferences

June 12, 2023

From Achilles Therapeutics PLC

Via GlobeNewswire

3 Stocks With 1,000% Upside Potential ↗

May 21, 2023

If you're an investor comfortable with speculative bets, analysts are price targeting these stocks with 1000% upside.

Via InvestorPlace

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.